Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,489 | 103 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $194.77 | 13 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $171.56 | 12 | $0 (2022) |
| PFIZER INC. | $164.16 | 13 | $0 (2023) |
| Novo Nordisk Inc | $159.14 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.82 | 4 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $102.66 | 8 | $0 (2023) |
| Lilly USA, LLC | $94.12 | 7 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $77.44 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $56.79 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $56.60 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.61 | 2 | ABBVIE INC. ($17.61) |
| 2023 | $62.67 | 4 | ABBVIE INC. ($33.45) |
| 2022 | $39.08 | 3 | Kowa Pharmaceuticals America, Inc. ($26.81) |
| 2021 | $31.05 | 2 | Dompe US, Inc. ($17.52) |
| 2020 | $65.58 | 5 | Kowa Pharmaceuticals America, Inc. ($14.49) |
| 2019 | $392.54 | 29 | Kowa Pharmaceuticals America, Inc. ($56.45) |
| 2018 | $354.92 | 28 | AbbVie, Inc. ($53.56) |
| 2017 | $509.95 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($93.01) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: VACCINES | ||||||
| 03/07/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/07/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/29/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Obesity | ||||||
| 05/19/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $12.42 | General |
| Category: Cardiovascular | ||||||
| 04/21/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Cardiovascular | ||||||
| 06/01/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2021 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/25/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Diabetes | ||||||
| 02/18/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Obesity | ||||||
| 01/30/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Cardiovascular | ||||||
| 12/05/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Neuroscience | ||||||
| 11/27/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: Cardiovascular | ||||||
| 11/12/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Central Nervous System | ||||||
| 11/05/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Neuroscience | ||||||
| 09/17/2019 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: VACCINES | ||||||
| 09/09/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/03/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Endocrinology | ||||||
| 08/26/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/09/2019 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 658 | 823 | $146,452 | $42,561 |
| 2022 | 13 | 697 | 889 | $130,264 | $43,554 |
| 2021 | 14 | 694 | 856 | $122,086 | $75,946 |
| 2020 | 16 | 707 | 871 | $124,680 | $66,768 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 304 | $69,950 | $17,758 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 132 | 132 | $31,070 | $7,365 | 23.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $4,760 | $4,665 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 78 | $15,600 | $2,742 | 17.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 45 | 88 | $4,115 | $2,418 | 58.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 20 | 20 | $6,000 | $1,964 | 32.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $2,025 | $1,726 | 85.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,292 | $1,299 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 26 | $1,833 | $854.62 | 46.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $1,269 | $591.66 | 46.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 35 | 35 | $5,249 | $444.45 | 8.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 28 | $770.00 | $438.55 | 57.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $389.70 | $167.23 | 42.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 26 | $130.00 | $127.40 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 273 | $51,932 | $14,262 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 143 | 143 | $29,088 | $7,246 | 24.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $4,760 | $4,682 | 98.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 112 | $15,211 | $3,837 | 25.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 52 | 107 | $4,637 | $3,069 | 66.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $6,251 | $2,904 | 46.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 37 | 37 | $3,045 | $2,536 | 83.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 19 | 19 | $5,360 | $1,820 | 34.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 41 | $2,750 | $1,335 | 48.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $1,387 | $852.66 | 61.5% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 14 | 28 | $712.50 | $472.91 | 66.4% |
About Dr. Nicole Leo, D.O
Dr. Nicole Leo, D.O is a Family Medicine healthcare provider based in Marmora, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952340077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicole Leo, D.O has received a total of $1,489 in payments from pharmaceutical and medical device companies, with $33.61 received in 2024. These payments were reported across 103 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,489).
As a Medicare-enrolled provider, Leo has provided services to 2,756 Medicare beneficiaries, totaling 3,439 services with total Medicare billing of $228,829. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Marmora, NJ
- Active Since 06/05/2006
- Last Updated 06/19/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952340077
Products in Payments
- Livalo (Drug) $171.56
- Synthroid (Drug) $130.18
- Victoza (Drug) $82.68
- CHANTIX (Drug) $77.75
- OFEV (Drug) $68.33
- JANUVIA (Drug) $63.43
- PREVNAR - 13 (Biological) $60.48
- MYRBETRIQ (Drug) $56.60
- Ozempic (Drug) $51.63
- DALVANCE (Drug) $51.06
- TRULICITY (Drug) $50.01
- Trintellix (Drug) $49.86
- BYDUREON (Drug) $47.87
- Vascepa (Drug) $44.85
- EMGALITY (Drug) $44.11
- XARELTO (Drug) $43.08
- Prolia (Biological) $42.48
- AJOVY (Drug) $35.63
- JARDIANCE (Drug) $28.81
- FARXIGA (Drug) $27.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marmora
Dr. Melissa Hutchison, Md, MD
Family Medicine — Payments: $2,398
Gregory Herman, M.d, M.D
Family Medicine — Payments: $1,582
Wayne Schneider, M.d, M.D
Family Medicine — Payments: $217.53
Dr. Raymond Keller, Do, DO
Family Medicine — Payments: $11.32